Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
86°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Senti Biosciences, Inc. - Common Stock
(NQ:
SNTI
)
0.3820
+0.0020 (+0.53%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Senti Biosciences, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
Senti Bio Highlights Initial Gene Circuit Data From Collaborations at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
May 20, 2023
Five presentations showcase the modularity and applicability of Senti’s Gene Circuit technology in NK cells, T cells, AAVs, iPSCs, and macrophages
From
Senti Biosciences, Inc.
Via
GlobeNewswire
Senti Bio Announces First Quarter 2023 Results and Pipeline Updates
May 09, 2023
From
Senti Biosciences, Inc.
Via
GlobeNewswire
Senti Bio Announces Multiple Data Presentations at the American Society of Gene and Cell Therapy 2023 Annual Meeting
May 02, 2023
From
Senti Biosciences, Inc.
Via
GlobeNewswire
Expert Ratings for Senti Biosciences
March 24, 2023
Via
Benzinga
Senti Biosciences's Return On Capital Employed Insights
March 23, 2023
Via
Benzinga
Chardan Capital Maintains Buy Rating for Senti Biosciences: Here's What You Need To Know
January 30, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
April 20, 2023
During Thursday's session, 99 companies made new 52-week lows.
Via
Benzinga
Senti Bio Highlights Preclinical Data from Multiple Gene Circuit Enabled Cell Therapy Programs at Annual AACR Meeting
April 17, 2023
From
Senti Biosciences, Inc.
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Monday
April 17, 2023
On Monday, 141 companies reached new 52-week lows.
Via
Benzinga
Senti Bio to Participate in Upcoming Investor Conferences
April 14, 2023
From
Senti Biosciences, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
March 15, 2023
Via
Benzinga
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Senti Bioscience, Inc. (SNTI) Investigation
February 21, 2023
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Senti Biosciences Announces New Employment Inducement Grants
February 03, 2023
From
Senti Biosciences, Inc.
Via
GlobeNewswire
Senti Bio to Present at the SVB Securities Global Biopharma Conference
February 01, 2023
From
Senti Biosciences, Inc.
Via
GlobeNewswire
Amazon To Rally Around 29%? Here Are 10 Other Analyst Forecasts For Monday
January 30, 2023
Barclays cut the price target for Amazon.com, Inc. (NASDAQ: AMZN) from $140 to $130. Barclays analyst Ross Sandler maintained an Overweight rating. Amazon shares fell 1.2% to $101.06 in pre-market...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
January 27, 2023
Via
Benzinga
Senti Bio Announces Pipeline Prioritization to Focus on Logic Gated Cell Therapies; Updates Cash Runway Guidance
January 27, 2023
From
Senti Biosciences, Inc.
Via
GlobeNewswire
Senti Bio to Present at 41st Annual J.P. Morgan Healthcare Conference
December 19, 2022
From
Senti Biosciences, Inc.
Via
GlobeNewswire
Why Innate Pharma Shares Are Trading Higher By 24%; Here Are 34 Stocks Moving Premarket
December 19, 2022
Gainers AIM ImmunoTech Inc. (NYSE: AIM) shares rose 82.4% to $0.62 in pre-market trading. AIM ImmunoTech recently reported safety, tolerability and biological activity data for intranasal ampligen in...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
December 14, 2022
We're starting off the day with an overview of the biggest pre-market stock movers traders need to know about on Wednesday!
Via
InvestorPlace
Why Netcapital Shares Are Trading Lower By Over 33%? Here Are 50 Stocks Moving In Wednesday's Mid-Day Session
December 14, 2022
Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares rose 153% to $0.3325 after gaining 14% on Tuesday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18 per share.
Via
Benzinga
Why Vallon Pharmaceuticals Shares Are Trading Higher By Over 150%; Here Are 29 Stocks Moving Premarket
December 14, 2022
Gainers Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) shares rose 150.9% to $0.6313 in pre-market trading after the company entered into a definitive merger agreement with GRI Bio.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
December 13, 2022
Via
Benzinga
Senti Bio Highlights Preclinical Data from Logic-Gated Gene Circuit CAR-NK Cell Therapy SENTI-202 at ASH Annual Meeting and Investor Event
December 11, 2022
From
Senti Biosciences, Inc.
Via
GlobeNewswire
Senti Bio to Host Investor Event Highlighting SENTI-202 at the 2022 ASH Annual Meeting
November 23, 2022
From
Senti Biosciences, Inc.
Via
GlobeNewswire
Cathie Wood Increases Stake In 4 Stocks By Over 1,000% - Plus 4 New Holdings For Ark
November 22, 2022
Cathie Wood’s ARK Innovation ETF (ARCA: ARKK) is down roughly 63% year-to-date, compared to the NASDAQ which is down at least 29% year-to-date and the S&P 500 down over 16% year-to-date.
Via
Benzinga
Senti Bio Reports Third Quarter Financial Results and Pipeline Updates
November 10, 2022
From
Senti Biosciences, Inc.
Via
GlobeNewswire
Senti Bio to Present Preclinical Data for SENTI-202 at the 2022 ASH Annual Meeting
November 03, 2022
Poster presentation to highlight preclinical data for SENTI-202 which employs Logic Gating gene circuit technology in off-the-shelf CAR-NK cells designed to more precisely target CD33 and/or FLT3...
From
Senti Biosciences, Inc.
Via
GlobeNewswire
Senti Bio Announces New Employment Inducement Grants
October 28, 2022
From
Senti Biosciences, Inc.
Via
GlobeNewswire
Why Snap Shares Are Trading Sharply Lower; Here Are 25 Stocks Moving Premarket
October 21, 2022
Gainers Statera Biopharma, Inc. (NASDAQ: STAB) rose 40.9% to $0.2160 in pre-market trading. Statera Biopharma recently signed a binding Memorandum of Understanding with Holobeam Technologies Inc.
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.